{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:31:41Z","timestamp":1776148301962,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.humimm.2023.110742","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T12:58:39Z","timestamp":1702645119000},"page":"110742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ankylosing spondylitis status and risk of secondary systemic amyloidosis: A two-sample mendelian randomization study"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8206-6449","authenticated-orcid":false,"given":"Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2023.110742_b0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0040-1708059","article-title":"Amyloid in the Lung[J]","volume":"41","author":"Baqir","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/JPER.17-0243","article-title":"Serum, salivary, and tissue levels of plasminogen in familial Mediterranean fever, amyloidosis, and chronic periodontitis[J]","volume":"89","author":"Fentoglu","year":"2018","journal-title":"J. Periodontol."},{"key":"10.1016\/j.humimm.2023.110742_b0015","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1156","article-title":"Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma[J]","volume":"14","author":"Algarra","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Secondary, AA, Amyloidosis[J]","volume":"44","author":"Papa","year":"2018","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"7","key":"10.1016\/j.humimm.2023.110742_b0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.medcli.2014.05.024","article-title":"Systemic secondary AA amyloidosis][J","volume":"144","author":"Cadinanos","year":"2015","journal-title":"Med. Clin. (Barc.)"},{"issue":"7","key":"10.1016\/j.humimm.2023.110742_b0030","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989[J]","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study[J]","volume":"161","author":"Pinney","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13506129.2016.1207626","article-title":"Incidence rate of amyloidosis in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort[J]","volume":"23","author":"Aguirre","year":"2016","journal-title":"Amyloid"},{"issue":"23","key":"10.1016\/j.humimm.2023.110742_b0045","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis[J]","volume":"356","author":"Lachmann","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.humimm.2023.110742_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010916","article-title":"Biomarkers in AL Amyloidosis[J]","volume":"22","author":"Fotiou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0055","first-page":"81","article-title":"Amyloidosis. Part II. Implications for neuroscience nurses: Alzheimer's disease[J]","volume":"13","author":"Day","year":"1992","journal-title":"Axone"},{"issue":"12","key":"10.1016\/j.humimm.2023.110742_b0060","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s10067-007-0679-x","article-title":"Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients[J]","volume":"26","author":"Kobak","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.humimm.2023.110742_b0065","doi-asserted-by":"crossref","first-page":"1759720X","DOI":"10.1177\/1759720X211040696","article-title":"Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjogren's syndrome: a literature review[J]","volume":"13","author":"Depascale","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.abd.2020.07.012","article-title":"Systemic amyloidosis manifestation in a patient with psoriatic arthritis[J]","volume":"96","author":"Souza","year":"2021","journal-title":"An. Bras. Dermatol."},{"issue":"46","key":"10.1016\/j.humimm.2023.110742_b0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7748\/ns.20.46.48.s56","article-title":"Ankylosing spondylitis[J]","volume":"20","author":"Walker","year":"2006","journal-title":"Nurs. Stand."},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/1744666X.2022.2038134","article-title":"Tofacitinib for the treatment of active ankylosing spondylitis in adults[J]","volume":"18","author":"Mohanakrishnan","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis[J]","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.humimm.2023.110742_b0090","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis[J]","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"6","key":"10.1016\/j.humimm.2023.110742_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.915","article-title":"Prevalence and complication of COVID-19 in patients with ankylosing spondylitis (AS) and its relationship with TNF-a inhibitors[J]","volume":"11","author":"Movassaghi","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"8","key":"10.1016\/j.humimm.2023.110742_b0100","article-title":"Complete bilateral ankle fusion: a rare complication of ankylosing spondylitis[J]","volume":"14","author":"El-Fanek","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.humimm.2023.110742_b0105","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/rheumatology\/keab633","article-title":"The risk, predictors and outcomes of amyloidosis in ankylosing spondylitis: a longitudinal population-based cohort study[J]","volume":"61","author":"Kridin","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0110","first-page":"299","article-title":"The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up[J]","volume":"38","author":"Yilmaz","year":"2013","journal-title":"Acta Reumatol. Port."},{"issue":"2","key":"10.1016\/j.humimm.2023.110742_b0115","first-page":"371","article-title":"Prevalence of subclinical amyloidosis in ankylosing spondylitis[J]","volume":"34","author":"Singh","year":"2007","journal-title":"J. Rheumatol."},{"issue":"19","key":"10.1016\/j.humimm.2023.110742_b0120","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian Randomization[J]","volume":"318","author":"Emdin","year":"2017","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in mendelian randomization studies[J]","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"issue":"16","key":"10.1016\/j.humimm.2023.110742_b0130","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement[J]","volume":"326","author":"Skrivankova","year":"2021","journal-title":"J. Am. Med. Assoc."},{"issue":"11","key":"10.1016\/j.humimm.2023.110742_b0135","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data[J]","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.humimm.2023.110742_b0140","article-title":"Causal relationships between total physical activity and ankylosing spondylitis: A mendelian randomization study[J]","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110742_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.587876","article-title":"Bidirectional causal associations between inflammatory bowel disease and ankylosing spondylitis: a two-sample Mendelian randomization analysis[J]","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/nu15041057","article-title":"No evidence of a genetic causal relationship between ankylosing spondylitis and gut microbiota: a two-sample Mendelian randomization study[J]","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.humimm.2023.110742_b0155","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators[J]","volume":"178","author":"Pierce","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.humimm.2023.110742_b0160","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1007\/s11033-022-07456-4","article-title":"HLA-B27 may modulate the interaction between ERAP1 polymorphisms and smoking in ankylosing spondylitis patients[J]","volume":"49","author":"Fernandez-Torres","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.humimm.2023.110742_b0165","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001510","article-title":"The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis[J]","volume":"7","author":"Turk","year":"2021","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.humimm.2023.110742_b0170","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/acr.24565","article-title":"Relationship between body mass index, disease activity, and exercise in ankylosing spondylitis[J]","volume":"74","author":"Liew","year":"2022","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"1","key":"10.1016\/j.humimm.2023.110742_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15436-8","article-title":"Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study[J]","volume":"12","author":"Kwon","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.humimm.2023.110742_b0180","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/rheumatology\/keaa506","article-title":"Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study[J]","volume":"60","author":"Dan","year":"2021","journal-title":"Rheumatology (oxford)"},{"issue":"11","key":"10.1016\/j.humimm.2023.110742_b0185","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization[J]","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator[J]","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"issue":"7121","key":"10.1016\/j.humimm.2023.110742_b0195","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures[J]","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","article-title":"Cochran's Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy[J]","volume":"68","author":"Cohen","year":"2015","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.humimm.2023.110742_b0205","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00296-012-2646-3","article-title":"Secondary amyloidosis in ankylosing spondylitis[J]","volume":"33","author":"Donmez","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.humimm.2023.110742_b0210","article-title":"Successful treatment of AA amyloidosis in ankylosing spondylitis using tocilizumab: report of two cases and review of the literature[J]","volume":"8","author":"Eriksson","year":"2021","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.humimm.2023.110742_b0215","doi-asserted-by":"crossref","unstructured":"E. Birney, Mendelian Randomization[J], Cold Spring Harb Perspect Med 12(4) (2022).","DOI":"10.1101\/cshperspect.a041302"},{"key":"10.1016\/j.humimm.2023.110742_b0220","doi-asserted-by":"crossref","unstructured":"E. Sanderson, Multivariable mendelian randomization and mediation[J], Cold Spring Harb Perspect Med 11(2) (2021).","DOI":"10.1101\/cshperspect.a038984"},{"issue":"R1","key":"10.1016\/j.humimm.2023.110742_b0225","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies[J]","volume":"23","author":"Davey","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humimm.2023.110742_b0230","doi-asserted-by":"crossref","unstructured":"B.A. Ference, M.V. Holmes, G.D. Smith, Using mendelian randomization to improve the design of randomized trials[J], Cold Spring Harb. Perspect. Med. 11(7) (2021).","DOI":"10.1101\/cshperspect.a040980"},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0235","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2022.10.028","article-title":"Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review[J]","volume":"103","author":"Karam","year":"2023","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.humimm.2023.110742_b0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.revmed.2022.12.004","article-title":"French practical guidelines for the diagnosis and management of AA amyloidosis[J]","volume":"44","author":"Georgin-Lavialle","year":"2023","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.humimm.2023.110742_b0245","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-3-030-41769-7_17","article-title":"Serum amyloid A (SAA) proteins[J]","volume":"94","author":"Sack","year":"2020","journal-title":"Subcell. Biochem."},{"issue":"2","key":"10.1016\/j.humimm.2023.110742_b0250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.23736\/S0026-4806.21.07599-6","article-title":"The role and prognostic value of human peripheral blood interleukin-27, C-reactive protein, and serum amyloid a in inflammatory response of sepsis[J]","volume":"114","author":"Maimaiti","year":"2023","journal-title":"Minerva Med."},{"key":"10.1016\/j.humimm.2023.110742_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110621","article-title":"Potential clinical value of serum interleukin-41 levels in patients with acute gout[J]","volume":"122","author":"Zhou","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2023.110742_b0260","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/IJGM.S310677","article-title":"The value of serum amyloid a in the diagnosis and management of ankylosing spondylitis[J]","volume":"14","author":"Hu","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"5","key":"10.1016\/j.humimm.2023.110742_b0265","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis[J]","volume":"60","author":"van Eijk","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.humimm.2023.110742_b0270","first-page":"912","article-title":"Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration[J]","volume":"24","author":"Gratacos","year":"1997","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0275","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4103\/ijpm.ijpm_461_21","article-title":"Secondary amyloidosis with concomitant gastric GIST and gastric adenocarcinoma \u2013 a case report[J]","volume":"66","author":"Soni","year":"2023","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"1","key":"10.1016\/j.humimm.2023.110742_b0280","doi-asserted-by":"crossref","first-page":"74","DOI":"10.31138\/mjr.32.1.74","article-title":"Gout and AA-amyloidosis: a case-based review[J]","volume":"32","author":"Gromova","year":"2021","journal-title":"Mediterr J Rheumatol"},{"issue":"4","key":"10.1016\/j.humimm.2023.110742_b0285","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.4049\/jimmunol.177.4.2601","article-title":"Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis[J]","volume":"177","author":"Ray","year":"2006","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2023.110742_b0290","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.18.12.7327","article-title":"Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter[J]","volume":"18","author":"Ray","year":"1998","journal-title":"Mol. Cell Biol."},{"issue":"5\u20136","key":"10.1016\/j.humimm.2023.110742_b0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.18632\/oncoscience.483","article-title":"Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level[J]","volume":"6","author":"Ray","year":"2019","journal-title":"Oncoscience"},{"issue":"3","key":"10.1016\/j.humimm.2023.110742_b0300","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.4049\/jimmunol.178.3.1774","article-title":"Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor[J]","volume":"178","author":"Ray","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2023.110742_b0305","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.fsi.2013.02.019","article-title":"Immune modulatory effects of Aloe arborescens extract on the piscine SAF-1 cell line[J]","volume":"34","author":"Picchietti","year":"2013","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"10.1016\/j.humimm.2023.110742_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112895","article-title":"Comprehensive analysis of differentially expressed mRNA and circRNA in Ankylosing spondylitis patients' platelets[J]","volume":"409","author":"Wang","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.humimm.2023.110742_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2021.1995860","article-title":"The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease[J]","volume":"55","author":"Kong","year":"2022","journal-title":"Autoimmunity"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:59:53Z","timestamp":1759319993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923003774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0198885923003774"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110742","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ankylosing spondylitis status and risk of secondary systemic amyloidosis: A two-sample mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110742"}}